<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03470883</url>
  </required_header>
  <id_info>
    <org_study_id>REC-IPC 2017-035</org_study_id>
    <nct_id>NCT03470883</nct_id>
  </id_info>
  <brief_title>Predictive Factors for Failure or Success of Endoscopic Treatment of Superficial Colorectal Tumors</brief_title>
  <acronym>REC</acronym>
  <official_title>Predictive Factors for Failure or Success of Endoscopic Treatment of Superficial Colorectal Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the long-term complete remission rate (&gt; 12 months) after endoscopic treatment of
      early neoplastic colorectal lesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intra-mucous colorectal neoplasia lesions (or even with minimal mucosal infiltration),
      formerly treated surgically, are increasingly treated endoscopically.

      The IPC as a center for interventional endoscopy has been taking care of these lesions for
      several years.

      Resection techniques have diversified since the 2000s (polypectomy, monobloc or piecemeal
      mucosectomy, submucosal dissection ... etc) and the endoscopy team has developed its various
      techniques within the institute ; Practice has evolved and has not been studied or evaluated
      in recent years. The purpose of this study is to evaluate practices and to compare results
      with the literature, and to identify predictive factors for the failure or success of
      endoscopic treatment of these early neoplastic lesions.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2012</start_date>
  <completion_date type="Actual">November 2, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complete long-term remission (&gt; 12 months)</measure>
    <time_frame>13 months</time_frame>
    <description>Evaluation of the long-term complete remission rate (&gt; 12 months)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absence of residual lesion on early control (3 to 6 months)</measure>
    <time_frame>3 to 6 months</time_frame>
    <description>Medium-term response rate (3 to 6 months)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of medium and long-term recurrence</measure>
    <time_frame>13 months</time_frame>
    <description>Recurrence rate in the medium and long term</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Management of medium and long-term recurrence</measure>
    <time_frame>13 months</time_frame>
    <description>Management of recurrence (endoscopic revision or surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity and mortality rates</measure>
    <time_frame>13 months</time_frame>
    <description>Morbidity and mortality rate of endoscopic resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymph node or visceral metastatic evolution rate</measure>
    <time_frame>13 months</time_frame>
    <description>Rate of pejorative lymph node or metastatic evolution (especially for lesions with microinfiltration of the submucosa)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endoscopic description and anatomopathological results</measure>
    <time_frame>1 day</time_frame>
    <description>Endoscopic and / or anatomopathological predictive factors of success (complete long-term remission)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Superficial Colorectal Tumors</condition>
  <arm_group>
    <arm_group_label>endoscopic resection of a colorectal lesion</arm_group_label>
    <description>Patient having undergone endoscopic resection of a colorectal lesion stage 4 or 5 of the modified Vienna classification during the last 5 years at the institute.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Evaluation of the long-term complete remission rate (&gt; 12 months)</intervention_name>
    <description>Evaluation of the long-term complete remission rate (&gt; 12 months)</description>
    <arm_group_label>endoscopic resection of a colorectal lesion</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient having undergone endoscopic resection of a colorectal lesion stage 4 or 5 of the
        modified Vienna classification
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient having undergone endoscopic resection of a colorectal lesion stage 4 or 5 of
             the modified Vienna classification during the last 5 years at the institute.

        Exclusion Criteria:

          -  Adenomas with low grade dysplasia

          -  Endoscopic control not available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Philippe RATONE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli-Calmettes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <state>Bouches Du Rhone</state>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002 Jul;51(1):130-1.</citation>
    <PMID>12077106</PMID>
  </reference>
  <reference>
    <citation>Repici A, Pellicano R, Strangio G, Danese S, Fagoonee S, Malesci A. Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. Dis Colon Rectum. 2009 Aug;52(8):1502-15. doi: 10.1007/DCR.0b013e3181a74d9b. Review.</citation>
    <PMID>19617768</PMID>
  </reference>
  <reference>
    <citation>Moss A, Williams SJ, Hourigan LF, Brown G, Tam W, Singh R, Zanati S, Burgess NG, Sonson R, Byth K, Bourke MJ. Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study. Gut. 2015 Jan;64(1):57-65. doi: 10.1136/gutjnl-2013-305516. Epub 2014 Jul 1.</citation>
    <PMID>24986245</PMID>
  </reference>
  <results_reference>
    <citation>Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, Jover R, Langner C, Bronzwaer M, Nalankilli K, Fockens P, Hazzan R, Gralnek IM, Gschwantler M, Waldmann E, Jeschek P, Penz D, Heresbach D, Moons L, Lemmers A, Paraskeva K, Pohl J, Ponchon T, Regula J, Repici A, Rutter MD, Burgess NG, Bourke MJ. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2017 Mar;49(3):270-297. doi: 10.1055/s-0043-102569. Epub 2017 Feb 17.</citation>
    <PMID>28212588</PMID>
  </results_reference>
  <results_reference>
    <citation>Belderbos TD, Leenders M, Moons LM, Siersema PD. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis. Endoscopy. 2014 May;46(5):388-402. doi: 10.1055/s-0034-1364970. Epub 2014 Mar 26. Review.</citation>
    <PMID>24671869</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2018</study_first_posted>
  <last_update_submitted>May 23, 2018</last_update_submitted>
  <last_update_submitted_qc>May 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endoscopic resection</keyword>
  <keyword>colorectal adenomas</keyword>
  <keyword>Colorectal adenocarcinomas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

